U.S. Healthtech Stock News

Schneider National, Inc. recently reported fourth-quarter 2025 results showing sales of US$1,399.6 million but lower net income of US$22.1 million, while also announcing a planned 2026 leadership transition, a quarterly dividend increase to US$0.10 per share, and a new three-year US$150 million share repurchase program. Together, these moves highlight Schneider’s emphasis on orderly succession, ongoing cash returns to shareholders, and measured use of buybacks to offset equity...

Nature's Sunshine Products, Inc. ( NASDAQ:NATR ) shares have continued their recent momentum with a 26% gain in the...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Oil-Dri Corporation of America ( NYSE:ODC ) shares have had a really impressive month, gaining 27% after a shaky period...

Shareholders might have noticed that General Dynamics Corporation ( NYSE:GD ) filed its annual result this time last...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights Given the large stake in the stock by institutions, NACCO Industries' stock price might be vulnerable to...

The board of Arrow Financial Corporation ( NASDAQ:AROW ) has announced that it will be paying its dividend of $0.30 on...

Key Insights The projected fair value for Middleby is US$148 based on 2 Stage Free Cash Flow to Equity Middleby's...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...

Despite an already strong run, Apyx Medical Corporation ( NASDAQ:APYX ) shares have been powering on, with a gain of...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Stoneridge, Inc. ( NYSE:SRI ) shareholders would be excited to see that the share price has had a great month, posting...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Innospec's estimated fair value is US$76.10 based on 2 Stage Free Cash Flow to Equity Innospec's US$83.50...

With a price-to-sales (or "P/S") ratio of 5.4x Geron Corporation ( NASDAQ:GERN ) may be sending very bullish signals at...

In the last year, many Laureate Education, Inc. ( NASDAQ:LAUR ) insiders sold a substantial stake in the company which...

If you are wondering whether Arthur J. Gallagher is priced attractively right now, it helps to step back and look at how the current share price lines up with its fundamentals. The stock last closed at US$245.27, after a 4.0% decline over the past week, a 4.2% decline over the last month, and a 19.9% decline over the past year, even though the 3 year and 5 year returns sit at 29.6% and 119.8% respectively. These moves have put valuation back on the radar for many investors, particularly when...

AZZ (AZZ) has implemented a new $100 million share repurchase program that will run alongside an earlier authorization that still has remaining capacity, with the stated goal of offsetting dilution from employee equity grants. See our latest analysis for AZZ. The share repurchase news lands after a strong run in AZZ’s share price, with a 30 day share price return of 16.38% and a 90 day share price return of 27.43%. The 1 year total shareholder return of 49.21% and 3 year total shareholder...

Archera’s expanded collaboration with Ingram Micro Holding (INGM) is putting cloud cost optimization and Insured Commitment products in front of more resellers and managed service providers across the US and Canada. See our latest analysis for Ingram Micro Holding. The collaboration news arrives at a time when Ingram Micro Holding’s short-term share price return has been slightly positive, while its 1-year total shareholder return of a 6.33% decline points to weaker longer-term momentum. If...

Elevance Health (ELV) has drawn investor attention after recent share price moves, with the stock down 9.3% over the past week and 3.5% over the month, despite longer term gains. See our latest analysis for Elevance Health. That recent 9.3% 7 day share price decline and 3.5% 30 day share price decline come after a 7.96% 90 day share price return. At the same time, the 1 year total shareholder return of 13.99% and 3 year total shareholder return of 25.28% indicate that momentum has been fading...

ServisFirst Bancshares, Inc. reported fourth-quarter 2025 results, with net interest income rising to US$146.52 million and net income increasing to US$86.38 million, while net charge-offs climbed to US$6.68 million from US$2.70 million a year earlier. The company’s higher basic and diluted earnings per share of US$1.58, up from US$1.19, highlight improved profitability despite higher credit costs. We’ll now examine how this earnings strength, particularly the increase in net interest...

eToro Group (NasdaqGS:ETOR) is preparing for major regulatory changes, including DORA enforcement from January 2025. Amendments to MiFID II are set to affect trading and transparency rules across its multi asset investment platform. A Payment for Order Flow ban scheduled for July 2026 is expected to influence how eToro structures parts of its revenue model. eToro operates a retail focused trading and investing platform that offers access to a broad mix of assets, including equities,...

Benchmark lithium prices have seen significant swings in recent months, creating a more volatile backdrop for producers. These price movements are directly affecting Albemarle (NYSE:ALB), a major supplier of lithium used in electric vehicle batteries and energy storage. Investors are watching closely as changing lithium prices influence Albemarle's contract terms, earnings sensitivity, and competitive position. Albemarle is one of the largest listed lithium producers, so sharp moves in...